MediWound to continue developing burn treatment for US Army

The Administration for Strategic Preparedness and Response (ASPR), part of the U.S. Department of Health and Human Services (HHS), today announced awards totaling $18.5 million to two U.S. companies to expand the nation’s manufacturing of key starting materials and active pharmaceutical ingredients needed to make essential medicines. The awards are the first through ASPR’s BioMaP-Consortium, a public-private partnership established in January 2024.

Finding new and creative ways to solve challenging problems like these is why MRDC partnered with MTEC, a nonprofit international consortium of over 600 academic institutions, small and large businesses, nonprofits and other organizations in the biomedical technology sector – most of which are small businesses that have not previously worked with the federal government.

Today the Department of Defense (DoD) announced the first award for the Distributed Bioindustrial Manufacturing Program (DBIMP) to expand the domestic supply of ingredients and materials for US-national supply chains and bolster the bioindustrial manufacturing base, as outlined in President Biden’s Executive Order 14081, "Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy."